AMRUTANJAN Intraday Analysis...

AMRUTANJAN Share Price

Open 608.00 Change Price %
High 634.70 1 Day 11.85 1.98
Low 595.00 1 Week -18.70 -2.97
Close 610.95 1 Month 15.75 2.65
Volume 8921 1 Year 172.90 39.47
52 Week High 784.20
52 Week Low 428.00
AMRUTANJAN Important Levels
Resistance 2 647.75
Resistance 1 632.59
Pivot 613.55
Support 1 589.31
Support 2 574.15
NSE INDIA Most Active Stocks
JPASSOCIAT 17.65 -4.85%
IBREALEST 254.15 5.15%
ITC 267.85 0.32%
ITC 267.85 0.32%
SUZLON 16.75 -0.89%
UNITECH 7.00 -2.10%
TATAMOTORS 423.65 4.62%
RCOM 20.10 -0.50%
KSK 12.00 2.13%
KSK 12.00 2.13%
More..
NSE INDIA Top Gainers Stocks
INDIAGLYCO 260.45 20.00%
HIRECT 123.95 19.99%
SILINV 225.20 19.98%
CGCL 120.15 19.97%
NELCO 125.55 19.97%
ASAL 93.15 19.96%
DHARSUGAR 27.65 19.96%
JAICORPLTD 132.80 19.96%
PRATIBHA 10.65 19.66%
VASWANI 22.40 19.47%
More..
NSE INDIA Top Losers Stocks
SPYL 0.30 -14.29%
XLENERGY 1.70 -10.53%
COMPUSOFT 14.95 -9.67%
UVSL 0.50 -9.09%
BRNL 194.50 -6.69%
ZODIACLOTH 189.85 -6.66%
SMPL 1.50 -6.25%
CNOVAPETRO 46.20 -6.19%
RTNPOWER 6.20 -6.06%
ONWARDTEC 115.00 -5.47%
More..

Amrutanjan Health Care Limited (NSE: AMRUTANJAN)

AMRUTANJAN Technical Analysis 3
As on 19th Sep 2017 AMRUTANJAN Share Price closed @ 610.95 and we RECOMMEND Sell for LONG-TERM with Stoploss of 614.90 & Sell for SHORT-TERM with Stoploss of 631.75 we also expect STOCK to react on Following IMPORTANT LEVELS.
AMRUTANJAN Target for September
1st Target up-side 649.75
2nd Target up-side 686.65
3rd Target up-side 723.55
1st Target down-side 544.45
2nd Target down-side 507.55
3rd Target down-side 470.65
Amrutanjan Health Care Limited ( NSE INDIA Symbol : AMRUTANJAN )
Sector : Pharmaceuticals - Formulations And Other Stocks in Same Sector
JAGSNPHARM
32.40 -1.40 (-4.14 %)
LT : Sell
ST : Sell
AMRUTANJAN
610.95 11.85 (1.98 %)
LT : Sell
ST : Sell
AMRUTANJAN Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 47.73 Sideways
MFI (14) MFI is 62.51 Sideways
CCI (20) CCI is 25.54 Sideways
WILLIAM %R (14) William %R is -63.56 Sideways
ADX (14) ADX is 19.42 Range Bound
PSAR Stoploss For Short Sell 641.25
10 Day Avg Volume Traded 135.26 % More then 10 Day Average Volume
AMRUTANJAN Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals - Formulations
Industry
Offical website
AMRUTANJAN Address
AMRUTANJAN
N/A
AMRUTANJAN Latest News
CRISIL ratings for Indian debt instruments-Mar 17   Reuters   - 17th Mar 15
Director resigns from Amrutanjan Health Care Ltd   Equity Bulls   - 13th Mar 15
Amrutanjan Healthcare Oct—Dec quarter net soars 29.5%   Hindu Business Line   - 05th Feb 15
Amrutanjan Health Care: Board declares interim dividend   Moneycontrol.com   - 05th Feb 15
Buy Amrutanjan Health Care Ltd. with a target of Rs 550: Prakash Gaba   Economic Times   - 08th Dec 14
Amrutanjan Health Care zooms over 50% in three days   Business Standard   - 21st Nov 14
CRISIL ratings for Indian debt instruments-Jan 1   Reuters   - 01st Jan 14
Amrutanjan Health Care (Rs 131): BUY   Hindu Business Line   - 25th Dec 13
Amrutanjan Health Care to split face value of share to   pharmabiz.com   - 11th Oct 12
Buy Amrutanjan Health; target Rs 870: Firstcall Research   Moneycontrol.com   - 08th Oct 12
Interactive Technical Analysis Chart Amrutanjan Health Care Limited ( AMRUTANJAN NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Amrutanjan Health Care Limited
AMRUTANJAN Business Profile
Amrutanjan Health Care Limited started in the year 1893 by the social reformer, journalist and freedom fighter, Desodharaka Sri.Nageswara Rao Pantulu Garu, today Amrutanjan is one of the household names in India.The company’s current offerings have been segregated to 3 sub brands: Kick Out Pain for pain management, Relief for congestion management and Purity for hygiene products. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc.Company is having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Limited having holding stake 99.80% & Amrutanjan Finance Limited, having holding stake is 57.26%. Amrutanjan company has reported a standalone sales of Rs 33.44 crore and a Net Profit of Rs 2.98 crore for the quarter ended September 2013. The Registered office is at No. 103 (Old No.42-45), Luz Church Road, Mylapore, Chennai, Tamil Nadu - 600004.